U.S. SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): September 28, 2004
AMEDISYS, INC.
Delaware
(State or Other Jurisdiction of
Incorporation or Organization)
0-24260 | 11-3131700 | |||
(Commission File Number) | (I.R.S. Employer Identification No.) |
11100 Mead Road, Suite 300, Baton Rouge, LA 70816
(Address of principal executive offices including zip code)
(225) 292-2031
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Securities Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-(c) under the Exchange Act (17 CFR 240.13e-(c))
ITEM 8.01 OTHER EVENTS | ||||||||
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS | ||||||||
SIGNATURES | ||||||||
Press Release dated September 28, 2004 |
ITEM 8.01 OTHER EVENTS
On September 28, 2004, Amedisys, Inc., issued a press release announcing the completion of its follow-on offering.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(a) |
Financial Statements of Business Acquired. | |||
Not applicable | ||||
(b) |
Pro Forma Financial Information | |||
Not applicable | ||||
(c) |
Exhibits | |||
99.1 Press release dated September 28, 2004 announcing the completion of follow-on offering. |